{"id":"https://openalex.org/W2149199906","doi":null,"title":"Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.","display_name":"Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.","publication_year":2007,"publication_date":"2007-02-01","ids":{"openalex":"https://openalex.org/W2149199906","mag":"2149199906","pmid":"https://pubmed.ncbi.nlm.nih.gov/17268022"},"language":"en","primary_location":{"id":"pmid:17268022","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17268022","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047331691","display_name":"Simon Mensah Ametamey","orcid":"https://orcid.org/0000-0003-4285-6731","observed_orcids":["https://orcid.org/0000-0003-4285-6731"]},"institutions":[{"id":"https://openalex.org/I35440088","display_name":"ETH Zurich","ror":"https://ror.org/05a28rw58","country_code":"CH","type":"education","lineage":["https://openalex.org/I2799323385","https://openalex.org/I35440088"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Simon M Ametamey","raw_affiliation_strings":["Center for Radiopharmaceutical Science of ETH, PSI, and USZ, Department of Chemistry and Applied Biosciences of ETH, Zurich, Switzerland. simon.ametamey@pharma.ethz.ch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Radiopharmaceutical Science of ETH, PSI, and USZ, Department of Chemistry and Applied Biosciences of ETH, Zurich, Switzerland. simon.ametamey@pharma.ethz.ch","institution_ids":["https://openalex.org/I35440088"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Valerie Treyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Valerie Treyer","raw_affiliation_strings":["University of Zurich Z\u00fcrich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Zurich Z\u00fcrich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018434240","display_name":"Johannes Rolf Streffer","orcid":"https://orcid.org/0000-0002-9387-5951","observed_orcids":["https://orcid.org/0000-0002-9387-5951","https://orcid.org/0000-0002-8122-8984"]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Johannes Streffer","raw_affiliation_strings":["University of Zurich Z\u00fcrich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Zurich Z\u00fcrich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007330714","display_name":"Matthias Tasso Wyss","orcid":"https://orcid.org/0000-0002-2037-3424","observed_orcids":["https://orcid.org/0000-0002-2037-3424"]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Matthias T Wyss","raw_affiliation_strings":["University of Zurich Z\u00fcrich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Zurich Z\u00fcrich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080344209","display_name":"Mark E. Schmidt","orcid":"https://orcid.org/0000-0003-3417-8977","observed_orcids":["https://orcid.org/0000-0003-3417-8977"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Mark Schmidt","raw_affiliation_strings":["Novartis International AG, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis International AG, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049067567","display_name":"Milen Blagoev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I35440088","display_name":"ETH Zurich","ror":"https://ror.org/05a28rw58","country_code":"CH","type":"education","lineage":["https://openalex.org/I2799323385","https://openalex.org/I35440088"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Milen Blagoev","raw_affiliation_strings":["ETH Zurich, Zurich, ZH, Switzerland#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ETH Zurich, Zurich, ZH, Switzerland#TAB#","institution_ids":["https://openalex.org/I35440088"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071832895","display_name":"Samuel Hintermann","orcid":"https://orcid.org/0000-0001-6853-6803","observed_orcids":["https://orcid.org/0000-0001-6853-6803"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Samuel Hintermann","raw_affiliation_strings":["Novartis International AG, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis International AG, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022765017","display_name":"Yves P. Auberson","orcid":"https://orcid.org/0000-0001-5800-4811","observed_orcids":["https://orcid.org/0000-0001-5800-4811"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Yves Auberson","raw_affiliation_strings":["Novartis International AG, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis International AG, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032192926","display_name":"Fabrizio Gasparini","orcid":"https://orcid.org/0000-0002-1315-563X","observed_orcids":["https://orcid.org/0000-0002-1315-563X"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Fabrizio Gasparini","raw_affiliation_strings":["Novartis International AG, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis International AG, Basel, Switzerland;","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103750085","display_name":"Uta C. Fischer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Uta C Fischer","raw_affiliation_strings":["University of Zurich Z\u00fcrich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Zurich Z\u00fcrich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103741765","display_name":"Alfred Buck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alfred Buck","raw_affiliation_strings":["University of Zurich Z\u00fcrich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Zurich Z\u00fcrich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.0397,"has_fulltext":false,"cited_by_count":163,"citation_normalized_percentile":{"value":0.95453635,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"48","issue":"2","first_page":"247","last_page":"52"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.486299991607666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.486299991607666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.3440000116825104,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.054499998688697815,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mglur5","display_name":"mGluR5","score":0.8870000243186951},{"id":"https://openalex.org/keywords/11c-abp688","display_name":"[11C]ABP688","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pet-radiotracer","display_name":"PET radiotracer","score":0.7070000171661377},{"id":"https://openalex.org/keywords/radioligand-development","display_name":"radioligand development","score":0.5950000286102295},{"id":"https://openalex.org/keywords/brain-receptor-distribution","display_name":"brain receptor distribution","score":0.5540000200271606},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.6930000185966492},{"id":"https://openalex.org/keywords/noncompetitive-antagonists","display_name":"noncompetitive antagonists","score":0.6019999980926514},{"id":"https://openalex.org/keywords/anterior-cingulate-cortex","display_name":"anterior cingulate cortex","score":0.5450000166893005},{"id":"https://openalex.org/keywords/amygdala","display_name":"amygdala","score":0.9089999794960022},{"id":"https://openalex.org/keywords/medial-temporal-lobe","display_name":"medial temporal lobe","score":0.8059999942779541},{"id":"https://openalex.org/keywords/tracer-metabolism","display_name":"tracer metabolism","score":0.3529999852180481},{"id":"https://openalex.org/keywords/dose-selection","display_name":"dose selection","score":0.3160000145435333}],"concepts":[{"id":"https://openalex.org/C2779714222","wikidata":"https://www.wikidata.org/wiki/Q550934","display_name":"Putamen","level":2,"score":0.5640295147895813},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5037359595298767},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.47161391377449036},{"id":"https://openalex.org/C2779652256","wikidata":"https://www.wikidata.org/wiki/Q130983","display_name":"Cerebellum","level":2,"score":0.46918320655822754},{"id":"https://openalex.org/C2777670902","wikidata":"https://www.wikidata.org/wiki/Q492038","display_name":"Human brain","level":2,"score":0.4258421063423157},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.4241669178009033},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3810632526874542},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3211873769760132},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2782491445541382},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21061405539512634},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19105398654937744},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.15441420674324036}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007553","descriptor_name":"Isotope Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064529","descriptor_name":"Receptor, Metabotropic Glutamate 5","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"pmid:17268022","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17268022","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.524.3655","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.524.3655","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnm.snmjournals.org/content/48/2/247.full.pdf","raw_type":"text"},{"id":"pmh:oai:dora:psi_82684","doi":null,"is_oa":false,"landing_page_url":"https://www.dora.lib4ri.ch/psi/item/psi:82684","pdf_url":null,"source":{"id":"https://openalex.org/S4306402574","display_name":"DORA PSI (Paul Scherrer Institute)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2802229908","host_organization_name":"Paul Scherrer Institute","host_organization_lineage":["https://openalex.org/I2802229908"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/62144","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/62144","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Ametamey, S. M., Treyer, V., Streffer, J., Wyss, M. T., Schmidt, M., Blagoev, M., Hintermann, S., Auberson, Y., Gasparini, F., Fischer, U. C., & Buck, A. (2007). Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. Journal of Nuclear Medicine, 48, 247\u2013252.","raw_type":"Journal Article"},{"id":"pmh:oai:www.zora.uzh.ch:49403","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/49403","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Ametamey, S M; Treyer, V; Streffer, J; Wyss, M T; Schmidt, M; Blagoev, M; Hintermann, S; Auberson, Y; Gasparini, F; Fischer, U C; Buck, A (2007). Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. Journal of Nuclear Medicine, 48(2):247-252.","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2149199906","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17268022","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1978157729","https://openalex.org/W1980080882","https://openalex.org/W2000029267","https://openalex.org/W2003472138","https://openalex.org/W2005872547","https://openalex.org/W2011606453","https://openalex.org/W2019281216","https://openalex.org/W2041044906","https://openalex.org/W2043166209","https://openalex.org/W2043824820","https://openalex.org/W2049157592","https://openalex.org/W2062912269","https://openalex.org/W2068273333","https://openalex.org/W2072818925","https://openalex.org/W2074592940","https://openalex.org/W2074682417","https://openalex.org/W2083937731","https://openalex.org/W2088947382","https://openalex.org/W2104451547","https://openalex.org/W2142635246","https://openalex.org/W2153464075","https://openalex.org/W2335967597","https://openalex.org/W2417578687"],"related_works":["https://openalex.org/W7111916819","https://openalex.org/W1988134168","https://openalex.org/W7099177199","https://openalex.org/W2163953059","https://openalex.org/W2165124532","https://openalex.org/W2050788857","https://openalex.org/W2770849010","https://openalex.org/W1969017796","https://openalex.org/W1964800033","https://openalex.org/W7208021007"],"abstract_inverted_index":{"UNLABELLED:":[0],"3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-11C-methyl-oxime":[1],"(11C-ABP688),":[2],"a":[3,23,85,97,241],"noncompetitive":[4],"and":[5,78,127,135,175,239,273,281],"highly":[6],"selective":[7],"antagonist":[8],"for":[9,19,64,245,258,274],"the":[10,65,68,119,133,159,176,180,218,259],"metabotropic":[11],"glutamate":[12],"receptor":[13],"subtype":[14],"5":[15],"(mGluR5),":[16],"was":[17,43,56,81,105,146,190,204,223],"evaluated":[18],"its":[20],"potential":[21],"as":[22,118,151],"PET":[24,49,243,275],"agent.":[25],"METHODS:":[26],"Six":[27],"healthy":[28,221],"male":[29],"volunteers":[30,222],"(mean":[31],"age,":[32],"25":[33],"y;":[34],"range,":[35],"21-33":[36],"y)":[37],"were":[38,72,111],"studied.":[39],"Brain":[40],"perfusion":[41],"(15O-H2O)":[42],"measured":[44,216],"immediately":[45],"before":[46],"each":[47,59],"11C-ABP688":[48,79,186,201,235],"scan.":[50],"For":[51],"anatomic":[52],"coregistration,":[53],"T1-weighted":[54],"MRI":[55],"performed":[57],"on":[58],"subject.":[60],"Arterial":[61],"blood":[62],"samples":[63],"determination":[66],"of":[67,93,144,155,179,185,200,214,220,230,255,261,264,277],"arterial":[69],"input":[70],"curve":[71],"obtained":[73],"at":[74,206],"predefined":[75],"time":[76],"points,":[77],"uptake":[80,92,131],"assessed":[82],"quantitatively":[83],"using":[84],"2-tissue-compartment":[86],"model.":[87],"RESULTS:":[88],"An":[89],"initial":[90],"rapid":[91],"radioactivity":[94,109,130,215],"followed":[95],"by":[96],"gradual":[98],"clearance":[99],"from":[100,164],"all":[101],"examined":[102],"brain":[103,115,161],"regions":[104,116,138,162,189],"observed.":[106],"Relatively":[107],"high":[108],"concentrations":[110],"observed":[112],"in":[113,132,158,187,202,217,249],"mGluR5-rich":[114],"such":[117],"anterior":[120],"cingulate,":[121],"medial":[122],"temporal":[123,191],"lobe,":[124],"amygdala,":[125],"caudate,":[126],"putamen,":[128],"whereas":[129],"cerebellum":[134],"white":[136],"matter,":[137],"known":[139],"to":[140,170,271],"contain":[141],"low":[142],"densities":[143],"mGluR5,":[145],"low.":[147],"Specific":[148],"distribution":[149,183,248],"volume":[150],"an":[152],"outcome":[153],"measure":[154],"mGluR5":[156,247,272],"density":[157],"various":[160],"ranged":[163],"5.45":[165],"+/-":[166,172,212],"1.47":[167],"(anterior":[168],"cingulate)":[169],"1.91":[171],"0.32":[173],"(cerebellum),":[174],"rank":[177],"order":[178],"corresponding":[181],"specific":[182],"volumes":[184],"cortical":[188],">":[192,194,196],"frontal":[193],"occipital":[195],"parietal.":[197],"The":[198,228],"metabolism":[199],"plasma":[203,219],"rapid;":[205],"60":[207],"min":[208],"after":[209],"injection,":[210],"25%":[211],"0.03%":[213],"intact":[224],"parent":[225],"compound.":[226],"CONCLUSION:":[227],"results":[229],"these":[231],"studies":[232,276],"indicate":[233],"that":[234,269],"has":[236],"suitable":[237],"characteristics":[238],"is":[240],"promising":[242],"ligand":[244],"imaging":[246],"humans.":[250],"Furthermore,":[251],"it":[252],"could":[253],"be":[254],"great":[256],"value":[257],"selection":[260],"appropriate":[262],"doses":[263],"clinically":[265],"relevant":[266],"candidate":[267],"drugs":[268],"bind":[270],"patients":[278],"with":[279],"psychiatric":[280],"neurologic":[282],"disorders.":[283]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":20},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}